DE602006005462D1 - Methode und Vektor zur Behandlung einer Nervenverletzung - Google Patents

Methode und Vektor zur Behandlung einer Nervenverletzung

Info

Publication number
DE602006005462D1
DE602006005462D1 DE602006005462T DE602006005462T DE602006005462D1 DE 602006005462 D1 DE602006005462 D1 DE 602006005462D1 DE 602006005462 T DE602006005462 T DE 602006005462T DE 602006005462 T DE602006005462 T DE 602006005462T DE 602006005462 D1 DE602006005462 D1 DE 602006005462D1
Authority
DE
Germany
Prior art keywords
nerve injury
vector
treatment
gene
injury site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006005462T
Other languages
English (en)
Inventor
Henrich Cheng
Pei-Teh Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602006005462D1 publication Critical patent/DE602006005462D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602006005462T 2005-12-09 2006-11-17 Methode und Vektor zur Behandlung einer Nervenverletzung Active DE602006005462D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/298,821 US20070134204A1 (en) 2005-12-09 2005-12-09 Method for treating nerve injury and vector construct for the same

Publications (1)

Publication Number Publication Date
DE602006005462D1 true DE602006005462D1 (de) 2009-04-16

Family

ID=38129395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006005462T Active DE602006005462D1 (de) 2005-12-09 2006-11-17 Methode und Vektor zur Behandlung einer Nervenverletzung

Country Status (7)

Country Link
US (1) US20070134204A1 (de)
EP (1) EP1825862B1 (de)
JP (1) JP2007161704A (de)
CN (1) CN1977976A (de)
AT (1) ATE424214T1 (de)
DE (1) DE602006005462D1 (de)
TW (1) TWI382848B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI434698B (zh) * 2009-08-14 2014-04-21 Eu Sol Biotech Co Ltd 人類酸性纖維母細胞生長因子之醫藥用途
JP2011121882A (ja) * 2009-12-09 2011-06-23 Eu Sol Biotech Co Ltd ヒト酸性繊維芽細胞増殖因子の改変ペプチド
CN106544326B (zh) * 2016-11-07 2020-06-26 中国科学院武汉病毒研究所 顺行跨多级突触、跨神经元的示踪系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
CA2098484A1 (en) * 1990-12-18 1992-06-19 Tsutomu Arakawa Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
EP0669987B1 (de) * 1992-09-25 2008-08-13 Aventis Pharma S.A. Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2716893B1 (fr) * 1994-03-03 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, leur préparation et leur utilisation thérapeutique.
US6551618B2 (en) * 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
FR2717495B1 (fr) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US6156303A (en) * 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6106826A (en) * 1997-12-17 2000-08-22 Wisconsin Alumni Research Foundation Replication competent, avirulent Herpes simplex virus as a vector for neural and ocular gene therapy
CA2356551A1 (en) * 1998-12-28 2000-07-06 Arch Development Corporation Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
SE0000285D0 (sv) * 1999-12-07 2000-01-31 Mika Lahtinen Medical implant
JP2005040005A (ja) * 2003-07-22 2005-02-17 Toray Ind Inc 組換えｄｎａ及びその用途
AU2004281764B2 (en) * 2003-10-14 2011-04-07 Neurologix Research, Inc. Methods and compositions for the treatment of neurological disease

Also Published As

Publication number Publication date
JP2007161704A (ja) 2007-06-28
US20070134204A1 (en) 2007-06-14
EP1825862B1 (de) 2009-03-04
EP1825862A1 (de) 2007-08-29
TW200733977A (en) 2007-09-16
CN1977976A (zh) 2007-06-13
ATE424214T1 (de) 2009-03-15
TWI382848B (zh) 2013-01-21

Similar Documents

Publication Publication Date Title
WO2014043547A8 (en) Method and apparatus for nitrogen removal in wastewater treatment
DK2195013T3 (da) Terapeutisk anvendelse af en vækstfaktor, METRNL
ATE541591T1 (de) Verfahren zur verringerung der viralen und mikrobiellen belastung von pankreatin
TW200519202A (en) Modulation of eIF4E expression
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
WO2009038720A3 (en) Method and apparatus for applying light therapy
DE602005019144D1 (de) Verfahren zur schmerzbehandlung in knochenkrebs du
WO2009021209A3 (en) Bi-layered bone-like scaffolds
BRPI0923821A2 (pt) "dispositivo para cultura de algas e/ou de microorganismos para o tratamento de um efluentes e de uma biofachada"
WO2005067374A3 (en) Method for treating biological waste
DE60314902D1 (de) Fehlpaarungsendonukleasen und verwendungsverfahren
ATE535231T1 (de) Verfahren zur herstellung von poly-iclc und seine verwendung
ATE447033T1 (de) Methode zur herstellung von pflanzen, welche eine unterdrückte photorespiration und eine verbesserte co2 fixierung aufweisen
WO2009140013A3 (en) Methods of reducing greenhouse emissions from animal manure
WO2014016816A3 (pt) Malha polímerica com permeabilidade seletiva, para a regeneraçâo/reparação de tecidos
DE602006005462D1 (de) Methode und Vektor zur Behandlung einer Nervenverletzung
WO2012004772A3 (en) Method for the preparation and the use of biocides enriched in active radicals before usage
WO2007019468A3 (en) Apparatus and method to treat a wound area
WO2010117992A3 (en) Coupled identification and treatment of cancer
ATE404230T1 (de) Implantat aus titan oder einer titanlegierung und verfahren zu seiner oberflächenbehandlung
BRPI0414175A (pt) método melhorado de tratamento de distúrbios do crescimento
WO2007021933A3 (en) Methods and compositions for use in treating vascular diseases and conditions
ATE510530T1 (de) Verfahren zur verhinderung und/oder behandlung von altersflecken
UA50654U (ru) Способ мутагенной обработки семян зайцехвоста яйцевидного (lagurus ovatus l.)
WO2009134396A3 (en) Use of corticotropin-releasing factor for the treatment of cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1825862

Country of ref document: EP

Representative=s name: PATENTANWAELTE BRESSEL UND PARTNER, 10785 BERLIN,